The current concept for Alzheimer's disease development involves the cleavage of amyloid precursor protein (APP) to amyloid beta (Aβ) peptide by BACE1 leading to the preliminary constituent of amyloid plaques in the brains of individuals with the disease [6]. The gene discussed is APP; the disease is Alzheimer disease.